---
title: COVID- 19 arveldamise ja litsentsiga seotud küsimused
ms.author: pebaum
author: pebaum
manager: scotv
ms.audience: Admin
ms.topic: article
ms.service: o365-administration
ROBOTS: NOINDEX, NOFOLLOW
localization_priority: Priority
ms.collection: Adm_O365
ms.custom:
- "1500005"
- "5110"
- "1500018"
- "5113"
- "9002647"
- "5091"
ms.openlocfilehash: 79ab97bbd788a84372a3ad7614f92f9a84a5c1cc6efbf9cc1d838858672a9ef9
ms.sourcegitcommit: b5f7da89a650d2915dc652449623c78be6247175
ms.translationtype: MT
ms.contentlocale: et-EE
ms.lasthandoff: 08/05/2021
ms.locfileid: "53929337"
---
# <a name="covid-19-billing-and-license-questions"></a>COVID- 19 arveldamise ja litsentsiga seotud küsimused

Vaadake uusimaid värskendusi ajaveebipostitusest [Meie pühendumus klientidele COVID-19 ajal](https://www.microsoft.com/microsoft-365/blog/2020/03/05/our-commitment-to-customers-during-covid-19/).  Kui teil on Covid-19 kriisiga seotud konkreetne arveldamise või litsentsimisega seotud küsimus, klõpsake selle lehe all suvandit **Tootetoe poole pöördumine**.
